Amring Pharmaceuticals is devoted to offering a broad variety of products in Oncology, Women’s Health, Anesthesiology & Pain Therapy, Respiratory, Rheumatology, Gastroenterology and Post-natal Diabetes.

At Amring we are committed to helping people improve, enhance and extend their life.


Our pharmaceutical products are quickly :



At Amring Pharmaceuticals our teams are highly motivated and focus on developing the operations in a very efficient way, avoiding bureaucracy and unproductive committees, which makes our decision process extremely quick, thanks to a very lean central organization.



Who we are

  • Senior Pharmaceutical Executives with track record in large scale companies (Bristol-Myers Squibb, Eli Lilly, Astra Zeneca, Wyeth, Fresenius, Ferring…) and in start-ups
  • Diversified, hands-on and result oriented
  • Experiences at global, regional or market level

What we bring

  • Expertise in the life sciences and adjacent activities
  • Agile business structure with a drive for success
  • Ability to quickly leverage global resources
    at a local level



Lausanne, Switzerland

2 Regional Hubs

Paris (Western Europe)
& Bucharest (Central Europe, CIS & Africa)

7 Affiliates

France, UK, Switzerland, USA,
Romania, Moldova, Georgia

6 Branch offices

Belarus, Kazakhstan, Uzbekistan, Kyrgyzstan, Azerbaijan, Ukraine

1 Production site

Chisinau (Moldova)

Product Commercialization
in 54 countries

Western Europe : France, UK, Sweden, Finland, Denmark, Norway, Spain, Portugal, Holland, Iceland

Central Europe & CIS : Romania, Bulgaria, Czech Republic, Hungary, Slovakia, Russia, Belarus, Ukraine, Moldova, Azerbaijan, Armenia, Georgia, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Estonia, Latvia, Lithuania

Africa : Kenya, Tanzania, Uganda, Zambia, Namibia, Botswana, Ethiopia, Angola, Somalia, Libya, Zimbabwe, South Africa

Asia : Vietnam, Laos, Cambodia, Mongolia, Kuwait

North America : USA, Canada

Latin America : Mexico, Columbia, Uruguay, Chile